<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02539940</url>
  </required_header>
  <id_info>
    <org_study_id>4448-06/15</org_study_id>
    <nct_id>NCT02539940</nct_id>
  </id_info>
  <brief_title>Elutax-SV Drug-eluting Balloons for Below-the-knee Treatment</brief_title>
  <acronym>Apollo</acronym>
  <official_title>A Prospective Observational Study Using Elutax-SV Drug-eluting Balloons for Below-the-knee Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jena University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zentrum für Klinische Studien Jena</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aachen Resonance GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Jena University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this observational study is to evaluate the outcomes and safety of the
      Paclitaxel-eluted balloon catheter ELUTAX SV for treatment of peripheral arterial disease
      (PAD) in below-the-knee vessels
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The management of critical limb ischemia due to below-the-knee disease remains challenging
      due to the frequent patient comorbidities, diffuse vascular involvement, limb preservation,
      and high rates of restenosis and disease progression. This study will record the use of
      ELUTAX SV-DEB under real life conditions in a representative sample.The investigators will
      generate new data in observing the outcome and the safety of the Elutax SV drug-eluting
      balloons for change in Rutherford clinical category from baseline to 6 and 12 month follow-up
      visits.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Rutherford Classification</measure>
    <time_frame>after 6 and 12 month</time_frame>
    <description>Change of Rutherford stage to baseline at Follow-up visits</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Critical Limb Ischemia</condition>
  <condition>Peripheral Artery Disease</condition>
  <arm_group>
    <arm_group_label>Patients with critical limb ischemia</arm_group_label>
    <description>Patients undergoing endovascular intervention of below-the-knee arteries with ELUTAX SV DEB (drug-eluting balloon).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Angioplasty Paclitaxel-eluted balloon catheter ELUTAX SV</intervention_name>
    <description>Angioplasty for revascularization in below-the-knee arteries</description>
    <arm_group_label>Patients with critical limb ischemia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population comprises patients in Germany who undergo treatment with the ELUTAX
        SV-DEB that is applied for treatment of peripheral arterial disease (PAD) in below-the-knee
        vessels.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Paclitaxel-eluting balloon angioplasty in below-the-knee lesions with ELUTAX SV-DEB

          -  Age ≥ 18 years

          -  Signed informed consent

          -  documented Critical Limb Ischemia (CLI) in the target limb prior to the study

          -  Rutherford Category 4, 5 or 6

          -  ≥70% diameter stenosis or occlusion in the target lesion, including de-novo / in-stent
             restenosis/occlusion of target lesion

          -  Patent inflow artery

          -  Target vessel(s) diameter between 2 and 4 mm

          -  Target vessel(s) reconstitute(s) at or above the ankle

        Exclusion Criteria:

          -  Life expectancy below 50% within the next 12 months (as judged by the investigator)

          -  Planned major index limb amputation

          -  Acute limb ischemia (within last 14 days thrombectomy, atherectomy, or lysis)

          -  Application of DEB-eluting balloons except from ELUTAX SV in the same target limb
             (POBA is allowed)

          -  Patient unwilling or unlikely to comply with follow-up schedule
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Teichgräber Ulf, Prof. Dr. med.</last_name>
    <phone>+49 03641/9324831</phone>
    <email>ulf.teichgraeber@med.uni-jena.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>René Aschenbach, PD Dr. med.</last_name>
    <phone>+49 03641/9324816</phone>
    <email>rene.aschenbach@med.uni-jena.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>DRK Kliniken Berlin Köpenick</name>
      <address>
        <city>Berlin</city>
        <state>Brandenburg</state>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Mende, Dr. med.</last_name>
      <phone>0049-30-30353357</phone>
      <email>m.mende@drk-kliniken-berlin.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oberlausitz-Kliniken Bautzen</name>
      <address>
        <city>Bautzen</city>
        <state>Saxony</state>
        <zip>02625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kersten-Uwe Wahl, Dr. med.</last_name>
      <phone>0049-3591-3632030</phone>
      <email>Kersten.wahl@oberlausitz-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Städtisches Krankenhaus Dresden-Friedrichstadt</name>
      <address>
        <city>Dresden</city>
        <state>Saxony</state>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Stelzner, Dr. med.</last_name>
      <phone>0049-351-4801120</phone>
      <email>stelzner-ch@khdf.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Heinrich-Braun-Krankenhaus</name>
      <address>
        <city>Zwickau</city>
        <state>Saxony</state>
        <zip>08060</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Thalwitzer, Dr. med.</last_name>
      <phone>0049-375-51554838</phone>
      <email>Joerg.thalwitzer@hbk-zwickau.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Altenburger Land GmbH</name>
      <address>
        <city>Altenburg</city>
        <state>Thuringia</state>
        <zip>046600</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albrecht Bormann, Dr. med.</last_name>
      <phone>0049-3447-522099</phone>
      <email>dr.albrecht.bormann@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SRH-Waldklinikum</name>
      <address>
        <city>Gera</city>
        <state>Thuringia</state>
        <zip>07548</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Kroeßner, Dr. med.</last_name>
      <phone>0049-365-8281602</phone>
      <email>Tobias.kroessner@wkg.srh.de</email>
    </contact>
    <contact_backup>
      <last_name>Melissa Rohde</last_name>
      <phone>0049-365-8287796</phone>
      <email>melissa.rohde@wkg.srh.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Hospital Jena, Radiology</name>
      <address>
        <city>Jena</city>
        <state>Thuringia</state>
        <zip>07747</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>René Aschenbach, PD Dr.med.</last_name>
      <phone>0049 (0) 3641 9324816</phone>
      <email>rene.aschenbach@med.uni-jena.de</email>
    </contact>
    <contact_backup>
      <last_name>Laura Graziani</last_name>
      <phone>0049 (0) 3641 9324910</phone>
      <email>laura.graziani@med.uni-jena.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>MEDINOS Kliniken Sonneberg</name>
      <address>
        <city>Sonneberg</city>
        <state>Thuringia</state>
        <zip>96515</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus Thieme, Dr. med.</last_name>
      <phone>0049-3675-821234</phone>
      <email>marcus.thieme@medinos-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saale-Unstrut Klinikum Naumburg</name>
      <address>
        <city>Naumburg</city>
        <state>Thüringen</state>
        <zip>06618</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Götz, Dr. med.</last_name>
      <phone>0049-3445-721700</phone>
      <email>Linda.goetz@klinikum-burgenlandkreis.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kreiskrankenhaus Torgau &quot;J. Kentmann&quot; gGmbH</name>
      <address>
        <city>Torgau</city>
        <zip>04860</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Maiwald, Dr. med.</last_name>
      <phone>0049 3421 772670</phone>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2015</study_first_submitted>
  <study_first_submitted_qc>September 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2015</study_first_posted>
  <last_update_submitted>May 17, 2017</last_update_submitted>
  <last_update_submitted_qc>May 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jena University Hospital</investigator_affiliation>
    <investigator_full_name>Ulf Teichgräber</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Below-the-knee</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

